Search
for
Sort by
Research 61–90 of 1000+
- Endocrine control of benign prostatic hyperplasia
- Female Pattern Hair Loss
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- 5α-Reduced glucocorticoids: a story of natural selection
- Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
- Parkinson's disease and skin
- 12 Treatment of hirsutism with 5α-reductase inhibitors
- Gender Differences in Cardiac Hypertrophy
- Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways
- Lessons Learned from the First Decade of Laser-Assisted Drug Delivery
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Transcriptomic inspection revealed a possible pathway regulating the formation of the high-quality brush hair in Chinese Haimen goat ( <i>Capra hircus</i> )
- Intrinsic versus Extrinsic Aging: A Histopathological, Morphometric and Immunohistochemical Study of Estrogen Receptor β and Androgen Receptor
- Male androgenetic alopecia (Part II)
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Modulating testosterone pathway: a new strategy to tackle male skin aging?
- The connection of 5-alpha reductase inhibitors to the development of depression
- Glucocorticoid and Sex Hormone Receptors: Clinical Implications and Therapeutic Relevance
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Non‐ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia
- IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study
- Fractional erbium-doped yttrium aluminum garnet laser 2940 nm-assisted delivery of topical timolol solution for the treatment of histiocytoid hemangioma
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Nonablative Er:YAG Laser Treatment of Androgenetic Alopecia: A Clinical Observation
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- UNCONVENTIONAL PROTEIN SECRETION OF KERATIN 75 BY AMELOBLASTS IN VIVO
- 200 The relationship between the expression of cytokeratin 5/6 and clinicopathologic factors in invasive breast carcinoma